Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha Crowcroft

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Pediatrics|November 23, 2019
Measles Antibody Levels in Young InfantsMichelle Science, Rachel Savage, Alberto Severini, et al.
Canadian Journal of Microbiology|July 12, 2019
The evolving nature of <i>Bordetella pertussis</i> in Ontario, Canada, 2009-2017: strains with shifting genotypes and pertactin deficiencyRaymond S W Tsang, Michelle Shuel, Kirby Cronin, et al.
The Journal of Infection|February 15, 2026
Assessing measles immunity in individuals of childbearing age in Toronto, Ontario, CanadaSelma Osman, Michelle Science, Elizabeth McLachlan, et al.
Vaccine|October 12, 2023
Immunity of Canadians and risk of epidemics workshop - Conference reportShelly Bolotin, Selma Osman, Scott Halperin, et al.
The Journal of Infectious Diseases|November 2, 2019
What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic ReviewShelly Bolotin, Stephanie L Hughes, Nazish Gul, et al.
Frontiers in Public Health|March 21, 2022
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining ChallengesMateusz Hasso-Agopsowicz, Natasha Crowcroft, Robin Biellik, et al.
BMJ (Clinical Research Ed.)|February 5, 2011
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009Danuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
Human Vaccines & Immunotherapeutics|June 12, 2019
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) studyShelly Bolotin, Alberto Severini, Todd Hatchette, et al.
Vaccine|May 1, 2022
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) studySelma Osman, Natasha Crowcroft, Elizabeth McLachlan, et al.
Vaccines|August 26, 2023
Population-Level Risk Factors Related to Measles Case Fatality: A Conceptual Framework Based on Expert Consultation and Literature ReviewAlyssa N Sbarra, Mark Jit, Jonathan F Mosser, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Pediatrics|November 23, 2019
Measles Antibody Levels in Young InfantsMichelle Science, Rachel Savage, Alberto Severini, et al.
Canadian Journal of Microbiology|July 12, 2019
The evolving nature of <i>Bordetella pertussis</i> in Ontario, Canada, 2009-2017: strains with shifting genotypes and pertactin deficiencyRaymond S W Tsang, Michelle Shuel, Kirby Cronin, et al.
The Journal of Infection|February 15, 2026
Assessing measles immunity in individuals of childbearing age in Toronto, Ontario, CanadaSelma Osman, Michelle Science, Elizabeth McLachlan, et al.
Vaccine|October 12, 2023
Immunity of Canadians and risk of epidemics workshop - Conference reportShelly Bolotin, Selma Osman, Scott Halperin, et al.
The Journal of Infectious Diseases|November 2, 2019
What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic ReviewShelly Bolotin, Stephanie L Hughes, Nazish Gul, et al.
Frontiers in Public Health|March 21, 2022
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining ChallengesMateusz Hasso-Agopsowicz, Natasha Crowcroft, Robin Biellik, et al.
BMJ (Clinical Research Ed.)|February 5, 2011
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009Danuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
Human Vaccines & Immunotherapeutics|June 12, 2019
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) studyShelly Bolotin, Alberto Severini, Todd Hatchette, et al.
Vaccine|May 1, 2022
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) studySelma Osman, Natasha Crowcroft, Elizabeth McLachlan, et al.
Vaccines|August 26, 2023
Population-Level Risk Factors Related to Measles Case Fatality: A Conceptual Framework Based on Expert Consultation and Literature ReviewAlyssa N Sbarra, Mark Jit, Jonathan F Mosser, et al.
Pageof 5